COMMUNIQUÉS West-GlobeNewswire

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
28/07/2026
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive multiplex [...]
Pennant Announces Second Quarter 2026 Earnings Release and Call
28/07/2026
EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
EssilorLuxottica: Résultats T2/S1 2026 - Trajectoire solide du chiffre d’affaires à +9,7 % au S1, avec un T2 à +8,7 %. Rentabilité en hausse, avec un résultat opérationnel ajusté progressant de +15 %.
28/07/2026
Trajectoire solide du chiffre d’affaires 1 à +9,7 % au S1, avec un T2 à +8,7 % Rentabilité en hausse, avec un résultat opérationnel ajusté 1,2 progressant de +15 % Chiffre d’affaires du Groupe en hausse de +9,7 % au S1 [...]
Colorectal Cancer Doesn’t Care How Young You Are
28/07/2026
Alliance’s Never Too Young Taskforce Tackles Growing Crisis as Cases of the Deadliest Cancer Continue to Rise in People Under 50 Key Takeaways: This August, World Cancer Support Month, the Colorectal Cancer Alliance ( [...]
SodaSlim Introduces a Gummy Supplement Format as Part of Its Portfolio Expansion
28/07/2026
SodaSlim Gummies expand the company’s product portfolio following a coordinated development cycle covering formulation design, production planning, packaging preparation and quality review. New York City, July 28, 2026 [...]
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28/07/2026
Consolidated net revenue of € 1,410.8 million in the first half of 2026, +6.6% or +9.1% on a like-for-like basis ( 3) at constant exchange rates (CER); adverse FX impact of € 34.5 million (-2.6%) EBITDA ( 1) of € 540.2 [...]
Eurobio Scientific: Premier semestre 2026, Continuation de la transformation stratégique
28/07/2026
PREMIER SEMESTRE 2026, CONTINUATION DE LA TRANSFORMATION STRATEGIQUE Progression du chiffre d’affaires semestriel de 5% à 84,5 M€ Continuation de la stratégie du Groupe : Produits propriétaires : 37% du Chiffre d’ [...]
North Texas Plastic Surgery’s Dr. Sacha Obaid Named to Newsweek’s America’s Best Plastic Surgeons 2025 List
28/07/2026
Recognition spans five procedure categories, including breast augmentation, liposuction, rhinoplasty, eyelid surgery and tummy tuck SOUTHLAKE, Texas, July 28, 2026 (GLOBE NEWSWIRE) -- North Texas Plastic Surgery [...]
EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
28/07/2026
Solid revenue 1 trajectory at +9.7% in H1, with Q2 at +8.7% Increasing profitability, with Adj. Operating Profit 1,2 +15% Group’s revenue grew 9.7% in H1 at constant exchange rates 1 , with Q2 at +8.7% Retail comparable [...]
AscellaHealth Appoints Industry Veteran Johanna van Nijkerk as Vice President of Business Development to Advance National Accounts and Drive Growth of AscellaOne
28/07/2026
BERWYN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a full-spectrum pharmacy solutions provider rooted in specialty pharmacy expertise, today announces the appointment of Johanna van Nijkerk as vice president [...]
Eurobio Scientific: First half of 2026, Continuation of the strategic transformation
28/07/2026
FIRST HALF OF 2026, CONTINUATION OF THE STRATEGIC TRANSFORMATION First-half revenue up 5% to €84.5 million Continuation of the Group’s strategy: Proprietary products: 37% of revenue International expansion: 47% of [...]
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
28/07/2026
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook [...]
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
28/07/2026
The six-month pilot is designed to evaluate the potential scalability of bringing physician-ordered, blood-based OkaiDx laboratory-developed tests to patients in Canada Taipei, Taiwan, July 28, 2026 (GLOBE NEWSWIRE) -- [...]
Codexis to Report Second Quarter 2026 Financial Results on August 11
28/07/2026
REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it [...]
Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx
28/07/2026
A featured menopause telehealth option is now available to women exploring DARE to PLAY™, advancing Daré’s strategy to build a trusted women’s health ecosystem spanning products, education and access to care [...]
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
28/07/2026
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their [...]
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
28/07/2026
Commercial long-term deal with a large pharmaceutical company pursuing manufacturing and commercial regulatory approvals in major markets Customer commits to AGC Biologics’ new site in Yokohama for five commercial [...]
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
28/07/2026
Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived [...]
HealthBegins Launches Online Learning Platform to Scale ‘Upstreamist’ Movement with Expert-Led Instruction and Resources
28/07/2026
HealthBegins Academy combines expert instruction, applied frameworks and flexible learning formats to turn health equity strategies into sustainable, scalable practices PASADENA, Calif., July 28, 2026 (GLOBE NEWSWIRE [...]

Pages